Clinical Trial Update: Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating autologous platelet-rich plasma to improve endometrial thickness in women with thin endometrium or endometrial disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Disorder
• Thin Endometrium

Drugs mentioned

• Autologous Platelet-Rich Plasma (PRP) (platelet-rich plasma)

Snippet

Sponsor: University Magna Graecia | Conditions: Thin Endometrium, Endometrial Disorder | Phase 2 | Status: UNKNOWN